Based on the effects of gain-of-function mutations in other autoimmune diseases and the effects of mutations in the IL-10, IL-23, and NOD2 pathways, it appears likely that increased IRF5 expression will affect the response to TLR and Nod-like receptor sensing of bacterial antigens [14]. Here, IRF5 is linked to autoimmune disease.